메뉴 건너뛰기




Volumn 57, Issue 1, 2003, Pages 14-23

Perillyl alcohol mediated radiosensitization via augmentation of the Fas pathway in prostate cancer cells

Author keywords

Apoptosis; Cell cycle and Fas; Monoterpenes; Radiation

Indexed keywords

CAMPTOTHECIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FAS ANTIGEN; PERILLYL ALCOHOL;

EID: 0042830798     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10269     Document Type: Article
Times cited : (35)

References (48)
  • 1
    • 0036169418 scopus 로고    scopus 로고
    • Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001
    • Sarma AV, Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001. Semin Urol Oncol 2002;20(1):3-9.
    • (2002) Semin Urol Oncol , vol.20 , Issue.1 , pp. 3-9
    • Sarma, A.V.1    Schottenfeld, D.2
  • 2
    • 0036256059 scopus 로고    scopus 로고
    • Prostate cancer update
    • Rini BI, Small EJ. Prostate cancer update. Curr Opin Oncol 2002;14(3):286-291.
    • (2002) Curr Opin Oncol , vol.14 , Issue.3 , pp. 286-291
    • Rini, B.I.1    Small, E.J.2
  • 3
    • 0032323546 scopus 로고    scopus 로고
    • Management of hormone refractory prostate cancer: Current standards and future prospects
    • Oh WK, Kantoff PW. Management of hormone refractory prostate cancer: Current standards and future prospects [see comments]. J Urol 1998;160(4):1220-1229.
    • (1998) J Urol , vol.160 , Issue.4 , pp. 1220-1229
    • Oh, W.K.1    Kantoff, P.W.2
  • 4
    • 0036671675 scopus 로고    scopus 로고
    • Chemotherapy for androgen-independent prostate cancer
    • Petrylak DP. Chemotherapy for androgen-independent prostate cancer. Semin Urol Oncol 2002;20(3 Suppl 1):31-35.
    • (2002) Semin Urol Oncol , vol.20 , Issue.3 SUPPL. 1 , pp. 31-35
    • Petrylak, D.P.1
  • 5
    • 0034862531 scopus 로고    scopus 로고
    • Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven
    • Woynarowska BAL, Munoz RM, Bushong P, Waters SJ. Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven. Invest New Drugs 2001;19(4):283-291.
    • (2001) Invest New Drugs , vol.19 , Issue.4 , pp. 283-291
    • Woynarowska, B.A.L.1    Munoz, R.M.2    Bushong, P.3    Waters, S.J.4
  • 6
    • 0034657646 scopus 로고    scopus 로고
    • Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF)
    • Woynarowska BA, Woynarowski JM, Herzig MC, Roberts K, Higdon AL, MacDonald JR. Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF). Biochem Pharmacol 2000;59(10):1217-1226.
    • (2000) Biochem Pharmacol , vol.59 , Issue.10 , pp. 1217-1226
    • Woynarowska, B.A.1    Woynarowski, J.M.2    Herzig, M.C.3    Roberts, K.4    Higdon, A.L.5    MacDonald, J.R.6
  • 7
    • 0033819653 scopus 로고    scopus 로고
    • Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells
    • Woynarowska BA, Roberts K, Woynarowski JM, MacDonald JR, Herman TS. Targeting apoptosis by hydroxymethylacylfulvene in combination with gamma radiation in prostate tumor cells. Radiat Res 2000;154(4):429-438.
    • (2000) Radiat Res , vol.154 , Issue.4 , pp. 429-438
    • Woynarowska, B.A.1    Roberts, K.2    Woynarowski, J.M.3    MacDonald, J.R.4    Herman, T.S.5
  • 9
    • 0034883764 scopus 로고    scopus 로고
    • Paclitaxel and docetaxel in prostate cancer
    • Obasaju C, Hudes GR. Paclitaxel and docetaxel in prostate cancer. Hematol Oncol Clin North Am 2001;15(3):525-545.
    • (2001) Hematol Oncol Clin North Am , vol.15 , Issue.3 , pp. 525-545
    • Obasaju, C.1    Hudes, G.R.2
  • 10
    • 0033457887 scopus 로고    scopus 로고
    • A phase II study of docetaxel (taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B Trial 9780
    • Savarese D, Taplin ME, Halabi S, Hars V, Kreis W, Vogelzang N. A phase II study of docetaxel (taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B Trial 9780. Semin Oncol 1999;26(5 Suppl 17):39-44.
    • (1999) Semin Oncol , vol.26 , Issue.5 SUPPL. 17 , pp. 39-44
    • Savarese, D.1    Taplin, M.E.2    Halabi, S.3    Hars, V.4    Kreis, W.5    Vogelzang, N.6
  • 11
    • 0035340275 scopus 로고    scopus 로고
    • Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780
    • Cancer and Leukemia Group B
    • Savarese DM, Halabi S, Hars V, Akerley WL, Taplin ME, Godley PA, Hussain A, Small EJ, Vogelzang N. Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: A final report of CALGB 9780. Cancer and Leukemia Group B. J Clin Oncol 2001;19(9):2509-2516.
    • (2001) J Clin Oncol , vol.19 , Issue.9 , pp. 2509-2516
    • Savarese, D.M.1    Halabi, S.2    Hars, V.3    Akerley, W.L.4    Taplin, M.E.5    Godley, P.A.6    Hussain, A.7    Small, E.J.8    Vogelzang, N.9
  • 12
    • 0035886470 scopus 로고    scopus 로고
    • Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma
    • DiPaola RS, Chenven ES, Shih WJ, Lin Y, Amenta P, Goodin S, et al. Mitoxantrone in patients with prostate specific antigen progression after local therapy for prostate carcinoma. Cancer 2001;92(8):2065-2071.
    • (2001) Cancer , vol.92 , Issue.8 , pp. 2065-2071
    • DiPaola, R.S.1    Chenven, E.S.2    Shih, W.J.3    Lin, Y.4    Amenta, P.5    Goodin, S.6
  • 13
    • 0033452117 scopus 로고    scopus 로고
    • Approaches to the treatment of patients with hormone-sensitive prostate cancer
    • DiPaola RS. Approaches to the treatment of patients with hormone-sensitive prostate cancer. Semin Oncol 1999;26(5 Suppl 17):24-27.
    • (1999) Semin Oncol , vol.26 , Issue.5 SUPPL. 17 , pp. 24-27
    • DiPaola, R.S.1
  • 14
    • 0028826389 scopus 로고
    • RTOG's first quality of life study - RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer
    • Watkins-Bruner D, Scott C, Lawton C, DelRowe J, Rotman M, Buswell L, et al. RTOG's first quality of life study - RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 1995;33(4):901-906.
    • (1995) Int J Radiat Oncol Biol Phys , vol.33 , Issue.4 , pp. 901-906
    • Watkins-Bruner, D.1    Scott, C.2    Lawton, C.3    DelRowe, J.4    Rotman, M.5    Buswell, L.6
  • 15
    • 0028237218 scopus 로고
    • Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer
    • Beard C, Buswell L, Rose MA, Noll L, Johnson D, Coleman CN. Phase II trial of external beam radiation with etanidazole (SR 2508) for the treatment of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 1994;29(3):611-616.
    • (1994) Int J Radiat Oncol Biol Phys , vol.29 , Issue.3 , pp. 611-616
    • Beard, C.1    Buswell, L.2    Rose, M.A.3    Noll, L.4    Johnson, D.5    Coleman, C.N.6
  • 16
    • 0036284485 scopus 로고    scopus 로고
    • Metabolic radiotherapy: What role will it have in 2001?
    • George B, Douard MC, Rain JD. [Metabolic radiotherapy: What role will it have in 2001?]. Cancer Radiother 2002;6(3):188-200.
    • (2002) Cancer Radiother , vol.6 , Issue.3 , pp. 188-200
    • George, B.1    Douard, M.C.2    Rain, J.D.3
  • 17
    • 0030867207 scopus 로고    scopus 로고
    • Cancer chemoprevention and therapy by monoterpenes
    • Gould MN. Cancer chemoprevention and therapy by monoterpenes. Environ Health Perspect 1997;105(Suppl 4):977-979.
    • (1997) Environ Health Perspect , vol.105 , Issue.SUPPL. 4 , pp. 977-979
    • Gould, M.N.1
  • 18
    • 0029841196 scopus 로고    scopus 로고
    • Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer
    • Crowell PL, Siar Ayoubi A, Burke YD. Antitumorigenic effects of limonene and perillyl alcohol against pancreatic and breast cancer. Adv Exp Med Biol 1996;401:131-136.
    • (1996) Adv Exp Med Biol , vol.401 , pp. 131-136
    • Crowell, P.L.1    Siar Ayoubi, A.2    Burke, Y.D.3
  • 19
    • 0032980875 scopus 로고    scopus 로고
    • Prevention and therapy of cancer by dietary monoterpenes
    • Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr 1999;129(3):775S-778S.
    • (1999) J Nutr , vol.129 , Issue.3
    • Crowell, P.L.1
  • 20
    • 0032827382 scopus 로고    scopus 로고
    • Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines
    • Sahin MB, Perman SM, Jenkins G, Clark SS. Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines. Leukemia 1999;13(10):1581-1591.
    • (1999) Leukemia , vol.13 , Issue.10 , pp. 1581-1591
    • Sahin, M.B.1    Perman, S.M.2    Jenkins, G.3    Clark, S.S.4
  • 21
    • 0031427722 scopus 로고    scopus 로고
    • Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells
    • Stayrook KR, McKinzie JH, Burke YD, Burke YA, Crowell PL. Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis 1997;18(8):1655-1658.
    • (1997) Carcinogenesis , vol.18 , Issue.8 , pp. 1655-1658
    • Stayrook, K.R.1    McKinzie, J.H.2    Burke, Y.D.3    Burke, Y.A.4    Crowell, P.L.5
  • 22
    • 0029055687 scopus 로고
    • The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol
    • Gelb MH, Tamanoi F, Yokoyama K, Ghomashchi F, Esson K, Gould MN. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett 1995;91(2):169-175.
    • (1995) Cancer Lett , vol.91 , Issue.2 , pp. 169-175
    • Gelb, M.H.1    Tamanoi, F.2    Yokoyama, K.3    Ghomashchi, F.4    Esson, K.5    Gould, M.N.6
  • 23
    • 0029125753 scopus 로고
    • Differential effects of monoterpenes and lovastatin on RAS processing
    • Hohl RJ, Lewis K. Differential effects of monoterpenes and lovastatin on RAS processing. J Biol Chem 1995;270(29):17508-17512.
    • (1995) J Biol Chem , vol.270 , Issue.29 , pp. 17508-17512
    • Hohl, R.J.1    Lewis, K.2
  • 24
    • 0033561642 scopus 로고    scopus 로고
    • Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol
    • Ariazi EA, Satomi Y, Ellis MJ, Haag JD, Shi W, Sattler CA, et al. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res 1999;59(8):1917-1928.
    • (1999) Cancer Res , vol.59 , Issue.8 , pp. 1917-1928
    • Ariazi, E.A.1    Satomi, Y.2    Ellis, M.J.3    Haag, J.D.4    Shi, W.5    Sattler, C.A.6
  • 25
  • 27
    • 0033875499 scopus 로고    scopus 로고
    • Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies
    • Hudes GR, Szarka CE, Adams A, Ranganathan S, McCauley RA, Weiner LM, et al. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. Clin Cancer Res 2000;6(8):3071-3080.
    • (2000) Clin Cancer Res , vol.6 , Issue.8 , pp. 3071-3080
    • Hudes, G.R.1    Szarka, C.E.2    Adams, A.3    Ranganathan, S.4    McCauley, R.A.5    Weiner, L.M.6
  • 29
    • 0032932315 scopus 로고    scopus 로고
    • Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells
    • Del Bino G, Darzynkiewicz Z, Degraef C, Mosselmans R, Fokan D, Galand P. Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells. Cell Prolif 1999;32(1):25-37.
    • (1999) Cell Prolif , vol.32 , Issue.1 , pp. 25-37
    • Del Bino, G.1    Darzynkiewicz, Z.2    Degraef, C.3    Mosselmans, R.4    Fokan, D.5    Galand, P.6
  • 30
    • 0030964237 scopus 로고    scopus 로고
    • Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis
    • Uslu R, Borsellino N, Frost P, Garban H, Ng CP, Mizutani Y, et al. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis. Clin Cancer Res 1997;3(6):963-972.
    • (1997) Clin Cancer Res , vol.3 , Issue.6 , pp. 963-972
    • Uslu, R.1    Borsellino, N.2    Frost, P.3    Garban, H.4    Ng, C.P.5    Mizutani, Y.6
  • 31
    • 0032798761 scopus 로고    scopus 로고
    • Sensitization of immunoresistant prostate carcinoma cell lines to Fas/ Fas ligand-mediated killing by cytotoxic lymphocytes: Independence of de novo protein synthesis
    • Frost PJ, Belldegrun A, Bonavida B. Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: Independence of de novo protein synthesis. Prostate 1999;41(1):20-30.
    • (1999) Prostate , vol.41 , Issue.1 , pp. 20-30
    • Frost, P.J.1    Belldegrun, A.2    Bonavida, B.3
  • 33
    • 0031586323 scopus 로고    scopus 로고
    • Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity
    • Frost P, Ng CP, Belldegrun A, Bonavida B. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity. Cell Immunol 1997;180(1):70-83.
    • (1997) Cell Immunol , vol.180 , Issue.1 , pp. 70-83
    • Frost, P.1    Ng, C.P.2    Belldegrun, A.3    Bonavida, B.4
  • 34
    • 0037099557 scopus 로고    scopus 로고
    • Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma
    • Jiang J, Ulbright TM, Zhang S, Eckert GJ, Kao C, Gardner TA, et al. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Cancer 2002;95(2):296-300.
    • (2002) Cancer , vol.95 , Issue.2 , pp. 296-300
    • Jiang, J.1    Ulbright, T.M.2    Zhang, S.3    Eckert, G.J.4    Kao, C.5    Gardner, T.A.6
  • 35
    • 0031838286 scopus 로고    scopus 로고
    • Immunohistochemical study of Fas, Fas ligand, and interleukin-1 beta converting enzyme expression in human prostatic cancer
    • Sasaki Y, Ahmed H, Takeuchi T, Moriyama N, Kawabe K. Immunohistochemical study of Fas, Fas ligand, and interleukin-1 beta converting enzyme expression in human prostatic cancer. Br J Urol 1998;81(6):852-855.
    • (1998) Br J Urol , vol.81 , Issue.6 , pp. 852-855
    • Sasaki, Y.1    Ahmed, H.2    Takeuchi, T.3    Moriyama, N.4    Kawabe, K.5
  • 36
    • 0031834910 scopus 로고    scopus 로고
    • Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage
    • Hedlund TE, Duke RC, Schleicher MS, Miller GJ. Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage. Prostate 1998;36(2):92-101.
    • (1998) Prostate , vol.36 , Issue.2 , pp. 92-101
    • Hedlund, T.E.1    Duke, R.C.2    Schleicher, M.S.3    Miller, G.J.4
  • 37
  • 38
    • 0031742724 scopus 로고    scopus 로고
    • Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines
    • Bardon S, Picard K, Martel P. Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. Nutr Cancer 1998;32(1): 1-7.
    • (1998) Nutr Cancer , vol.32 , Issue.1 , pp. 1-7
    • Bardon, S.1    Picard, K.2    Martel, P.3
  • 39
    • 0031841099 scopus 로고    scopus 로고
    • Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells
    • Stayrook KR, McKinzie JH, Barbhaiya LH, Crowell PL. Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancreatic cells. Anticancer Res 1998;18(2A):823-828.
    • (1998) Anticancer Res , vol.18 , Issue.2 A , pp. 823-828
    • Stayrook, K.R.1    McKinzie, J.H.2    Barbhaiya, L.H.3    Crowell, P.L.4
  • 40
    • 0031944598 scopus 로고    scopus 로고
    • Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors
    • Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate 1998;35(2):95-101.
    • (1998) Prostate , vol.35 , Issue.2 , pp. 95-101
    • Han, E.K.1    Lim, J.T.2    Arber, N.3    Rubin, M.A.4    Xing, W.Q.5    Weinstein, I.B.6
  • 41
    • 0034713236 scopus 로고    scopus 로고
    • The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents
    • Rasmussen LJ, Rasmussen M, Lutzen A, Bisgaard HC, Singh KK. The human cyclin B1 protein modulates sensitivity of DNA mismatch repair deficient prostate cancer cell lines to alkylating agents. Exp Cell Res 2000;257(1):127-134.
    • (2000) Exp Cell Res , vol.257 , Issue.1 , pp. 127-134
    • Rasmussen, L.J.1    Rasmussen, M.2    Lutzen, A.3    Bisgaard, H.C.4    Singh, K.K.5
  • 42
    • 0034296761 scopus 로고    scopus 로고
    • Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis
    • Hyer ML, Voelkel-Johnson C, Rubinchik S, Dong J, Norris JS. Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis. Mol Ther 2000;2(4):348-358.
    • (2000) Mol Ther , vol.2 , Issue.4 , pp. 348-358
    • Hyer, M.L.1    Voelkel-Johnson, C.2    Rubinchik, S.3    Dong, J.4    Norris, J.S.5
  • 43
    • 0031746614 scopus 로고    scopus 로고
    • Fas ligand is constitutively secreted by prostate cancer cells in vitro
    • Liu QY, Rubin MA, Omene C, Lederman S, Stein CA. Fas ligand is constitutively secreted by prostate cancer cells in vitro. Clin Cancer Res 1998;4(7):1803-1811.
    • (1998) Clin Cancer Res , vol.4 , Issue.7 , pp. 1803-1811
    • Liu, Q.Y.1    Rubin, M.A.2    Omene, C.3    Lederman, S.4    Stein, C.A.5
  • 44
    • 0030824454 scopus 로고    scopus 로고
    • Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines
    • Rokhlin OW, Hostager BS, Bishop GA, Sidorenko SP, Glover RA, Gudkov AV, et al. Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 1997;57(18):3941-3943.
    • (1997) Cancer Res , vol.57 , Issue.18 , pp. 3941-3943
    • Rokhlin, O.W.1    Hostager, B.S.2    Bishop, G.A.3    Sidorenko, S.P.4    Glover, R.A.5    Gudkov, A.V.6
  • 45
    • 0032903236 scopus 로고    scopus 로고
    • Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis
    • Costa-Pereira AP, Cotter TG. Camptothecin sensitizes androgen-independent prostate cancer cells to anti-Fas-induced apoptosis. Br J Cancer 1999;80(3-4):371-378.
    • (1999) Br J Cancer , vol.80 , Issue.3-4 , pp. 371-378
    • Costa-Pereira, A.P.1    Cotter, T.G.2
  • 46
    • 0029739576 scopus 로고    scopus 로고
    • Modulation of growth and apoptosis response in PC-3 and LNCAP prostate-cancer cell lines by Fas
    • Takeuchi T, Sasaki Y, Ueki T, Kaziwara T, Moriyama N, Kawabe K, et al. Modulation of growth and apoptosis response in PC-3 and LNCAP prostate-cancer cell lines by Fas. Int J Cancer 1996;67(5):709-714.
    • (1996) Int J Cancer , vol.67 , Issue.5 , pp. 709-714
    • Takeuchi, T.1    Sasaki, Y.2    Ueki, T.3    Kaziwara, T.4    Moriyama, N.5    Kawabe, K.6
  • 47
    • 0344019488 scopus 로고    scopus 로고
    • The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis
    • Muller M, Scaffidi CA, Galle PR, Stremmel W, Krammer PH. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis. Eur Cytokine Netw 1998;9(4):685-686.
    • (1998) Eur Cytokine Netw , vol.9 , Issue.4 , pp. 685-686
    • Muller, M.1    Scaffidi, C.A.2    Galle, P.R.3    Stremmel, W.4    Krammer, P.H.5
  • 48
    • 0031743648 scopus 로고    scopus 로고
    • p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
    • Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998;188(11):2033-2045.
    • (1998) J Exp Med , vol.188 , Issue.11 , pp. 2033-2045
    • Muller, M.1    Wilder, S.2    Bannasch, D.3    Israeli, D.4    Lehlbach, K.5    Li-Weber, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.